HSBC upgrades Dr Reddy’s citing Semaglutide potential
Shares of Dr. Reddy’s Laboratories surged 4 percent to Rs 1,303 on June 5, making it one of the top gainers on the Nifty 50. The rally followed the company’s announcement of a strategic collaborat…
Dr Reddy’s Lab shares jump 4%, emerges top Nifty gainer on biosimilar deal with Alvotech
